Fundz

Embecta to acquire Owen Mumford Holdings Limited

PUBLIC · EMBCMar 19, 2026

Acquiring Company

Embecta

Acquired Company

Owen Mumford Holdings

United StatesCopenhagenManufacturingBiotechnologyHealth CareMedicalMedical DeviceManufacturingBiotechnologyHealth CareMedicalMedical Device

Description

Embecta has announced a definitive agreement to acquire Owen Mumford Holdings Limited. This acquisition aims to strengthen Embecta's position in the diabetes management sector. The partnership is expected to enhance innovative product development and customer solutions.

Quick answer

Embecta is acquiring Owen Mumford Holdings, announced March 19, 2026. Embecta is based in United States.

How much did Embecta pay for Owen Mumford Holdings?
The deal value was not disclosed.
What does Embecta do?
Embecta Corp. is a leading global medical technology company.
Where are Embecta and Owen Mumford Holdings based?
Embecta is based in United States. Owen Mumford Holdings is based in Copenhagen, Capital Region Of Denmark, Denmark.
Who are the decision-makers at Embecta?
Fundz holds 2 contacts at Embecta. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Medical and Medical Device

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Embecta, and when

When Embecta changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Embecta raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Embecta, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Embecta. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Embecta

Location

United States

About

Embecta Corp. is a leading global medical technology company. It specializes in diabetes management and related products. The company focuses on providing innovative solutions for diabetes care. Embecta aims to enhance patients' lives with its technology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Embecta makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Ken
Senior decision-maker at this company
••••••••@••••••••

See Ken's verified email →

Mark
Senior decision-maker at this company
••••••••@••••••••

See Mark's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Embecta's next move

Learn about Strategic plan

Frequently asked

Who acquired Owen Mumford Holdings?

Owen Mumford Holdings was acquired by Embecta, based in United States. The deal was reported on March 19, 2026. Embecta Corp. is a leading global medical technology company. It specializes in diabetes management and related products. The company focuses on providing innovative solutions for diabetes care. Embecta is publicly traded (EMBC) and operates in Manufacturing.

When did Embecta acquire Owen Mumford Holdings?

Embecta's acquisition of Owen Mumford Holdings was reported on March 19, 2026. Embecta has announced a definitive agreement to acquire Owen Mumford Holdings Limited. This acquisition aims to strengthen Embecta's position in the diabetes management sector. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Owen Mumford Holdings do?

Owen Mumford Holdings is a renowned manufacturer of medical devices. It offers a wide range of products designed for diabetes management and diagnostic testing. The company is known for its innovative approach in the medical technology field. It is privately held, operating in Manufacturing, and is based in Copenhagen.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.